Last updated 57 days ago

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

150 patients around the world

Available in Argentina, United States

Eli Lilly and Company

4Research sites

150Patients around the world

This study is for people with

Obesity

Diabetes

Diabetes mellitus type 2

To 75 Years

All Gender

: W8M-MC-GN02:
Assigned male at birth.
Assigned female at birth, who are of non-childbearing potential.
Have type 2 diabetes.
W8M-MC-CWMM:
Have a BMI ≥27 kilograms per square meter (kg/m²).
Have had a stable body weight for the 3 months prior to randomization.

: W8M-MC-GN02:
Individuals who are of childbearing potential.
Have a history of acute or chronic pancreatitis.
Have any of the following cardiovascular conditions within 6 months prior to screening.
Acute myocardial infarction.
Cerebrovascular accident (stroke).
Unstable angina.
Hospitalization due to congestive heart failure.
W8M-MC-CWMM:
Have a prior or planned surgical treatment for obesity, except prior liposuction or abdominoplasty, if performed >1 year prior to screening.
Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history of ketoacidosis or hyperosmolar coma.
Have poorly controlled hypertension.
Have signs and symptoms of any liver disease other than nonalcoholic fatty liver disease.
Have a history of symptomatic gallbladder disease within the past 2 years.
Have a lifetime history of suicide attempts.